# Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

> **NCT07537673** · PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 25 (estimated)

## Conditions studied

- Nausea and Vomiting Caused by Trastuzumab Deruxtecan

## Interventions

- **OTHER:** Auricular point stimulation plus dexamethasone

## Key facts

- **NCT ID:** NCT07537673
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-25
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07537673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07537673, "Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07537673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*